XML 21 R2.htm IDEA: XBRL DOCUMENT v3.25.1
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2024
Dec. 31, 2023
ASSETS    
Property and equipment, net (notes 4 and 10) $ 9,763 $ 10,551
Goodwill 13,580 13,692
Other intangible assets (note 2) 53,772 54,296
Other intangible assets - accumulated amortization (50,907) (49,350)
Other intangible assets - net (note 2) 2,865 4,946
Total assets 122,538 135,458
Current assets    
Cash 82,976 92,868
Accounts and other receivables, net (note 2) 4,094 3,391
Inventories (note 2) 8,812 9,582
Prepaid expenses and other current assets 448 428
Total current assets 96,330 106,269
LIABILITIES AND STOCKHOLDERS' EQUITY    
Long term lease liability 282 295
Long term income tax payable (REPAT tax) (note 7) 0 698
Deferred tax liability - intangible assets 603 1,120
Deferred income taxes (note 7) 469 322
Commitments and contingencies (notes 6 and 12) 0 0
Current liabilities    
Accounts payable 696 769
Accrued expenses (note 2) 3,061 3,941
Total current liabilities 3,757 4,710
Total liabilities 5,111 7,145
Stockholders' equity    
Common stock, $.01 par value; 50,000 shares authorized, issued 3,335 shares in 2024 and 3,630 shares in 2023 33 36
Accumulated other comprehensive loss (11,908) (10,658)
Additional paid-in capital 0 594
Retained earnings 129,302 138,341
Total stockholders' equity 117,427 128,313
Total liabilities and stockholders' equity $ 122,538 $ 135,458